Hedge Fund News From HedgeCo.Net

Arena Pharma Investors: DEA, Hedge Funds Conspiring To Destroy Belviq

TheStreet – Some of Arena Pharmaceuticals’ retail-investor shareholders accuse the U.S. Drug Enforcement Agency of conspiring with Wall Street hedge funds to delay the commercial launch of the company’s weight-loss pill Belviq.

The DEA is collecting public comments on its proposed rule making Belviq a Schedule IV controlled substance. The 30-day comment period ends on Jan. 18, after which DEA will finalize its ruling. After another 30-day waiting period, the rule becomes effective and Arena’s marketing partner Eisai can start selling Belviq and begin to compete against Vivus’ Qsymia.

Read Complete Article

Related Posts Plugin for WordPress, Blogger...
This entry was posted in Syndicated. Bookmark the permalink.

Leave a Reply